Share-based Payment Arrangement, Expense of Journey Medical Corp from 30 Sep 2021 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Journey Medical Corp quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Sep 2021 to 30 Sep 2025.
  • Journey Medical Corp Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $1,854,000, a 13% increase year-over-year.
  • Journey Medical Corp Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $5,891,000, a 12% increase year-over-year.
  • Journey Medical Corp annual Share-based Payment Arrangement, Expense for 2024 was $6,098,000, a 134% increase from 2023.
  • Journey Medical Corp annual Share-based Payment Arrangement, Expense for 2023 was $2,606,000, a 41% decline from 2022.
  • Journey Medical Corp annual Share-based Payment Arrangement, Expense for 2022 was $4,425,000, a 79% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Journey Medical Corp Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $5,891,000 $1,854,000 +$214,000 +13% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $5,677,000 $1,336,000 -$338,000 -20% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $6,015,000 $1,323,000 -$83,000 -5.9% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $6,098,000 $1,378,000 +$849,000 +160% 01 Oct 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
Q3 2024 $5,249,000 $1,640,000 +$1,082,000 +194% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 $4,167,000 $1,674,000 +$801,000 +92% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2
Q1 2024 $3,366,000 $1,406,000 +$760,000 +118% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q4 2023 $2,606,000 $529,000 -$911,000 -63% 01 Oct 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 $3,517,000 $558,000 -$880,000 -61% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $4,397,000 $873,000 +$99,000 +13% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $4,298,000 $646,000 -$127,000 -16% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q4 2022 $4,425,000 $1,440,000 01 Oct 2022 31 Dec 2022 10-K 29 Mar 2024 2023 FY
Q3 2022 $1,438,000 +$1,430,000 +17875% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 $774,000 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 $773,000 01 Jan 2022 31 Mar 2022 10-Q 22 May 2023 2023 Q1
Q3 2021 $8,000 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3

Journey Medical Corp Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $6,098,000 +$3,492,000 +134% 01 Jan 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
2023 $2,606,000 -$1,819,000 -41% 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
2022 $4,425,000 +$1,959,000 +79% 01 Jan 2022 31 Dec 2022 10-K 29 Mar 2024 2023 FY
2021 $2,466,000 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.